SCHEMBL25640703

SCHEMBL25640703

Cc1ccc2c3ccccc3n(-c3nc(C)nc(C)n3)c2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.38
MAPT P10636 2/20 0.38
HTT P42858 1/20 0.38
AURKA O14965 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP1A2 P05177 1/20 0.37
GABRP O00591 1/20 0.36
GABRD O14764 1/20 0.36
GABRA1 P14867 1/20 0.36
GABRB1 P18505 1/20 0.36
GABRG2 P18507 1/20 0.36
GABRB3 P28472 1/20 0.36
GABRA5 P31644 1/20 0.36
GABRA3 P34903 1/20 0.36
GABRA2 P47869 1/20 0.36
GABRB2 P47870 1/20 0.36
GABRA4 P48169 1/20 0.36
GABRE P78334 1/20 0.36
GABRA6 Q16445 1/20 0.36
GABRG1 Q8N1C3 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14407561 0.92 LMNA (0.41) LMNAMAPTHTTAURKAALDH1A1
SCHEMBL22926684 0.92 LMNA (0.41) LMNAMAPTHTTAURKAALDH1A1
SCHEMBL25640700 0.90 MEN1 (0.41) LMNAMAPTHTTAURKAALDH1A1
SCHEMBL17724031 0.88 KDM4E (0.45) LMNAMAPTHTTCYP1A2KDM4E
SCHEMBL27058776 0.87 MEN1 (0.41) LMNAMAPTHTTAURKAALDH1A1
SCHEMBL22926650 0.86 AURKA (0.37) LMNAMAPTHTTAURKAALDH1A1
SCHEMBL22926651 0.86 AURKA (0.37) LMNAMAPTHTTAURKAALDH1A1
SCHEMBL20313304 0.85 MTOR (0.44) LMNAMAPTHTTAURKAALDH1A1
SCHEMBL17051451 0.84 KDM4E (0.45) LMNAMAPTHTTCYP1A2KDM4E
SCHEMBL10052464 0.83 L3MBTL1 (0.43) LMNAMAPTHTTALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192665-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192665-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, ODC1 LMNA 2573/4885MAPT 1201/4885HTT 1443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.